Skip to main content

Table 2 Year-specific opioid filling volumes and rates across the entire study cohort in oxycodone 5-mg equivalents. Mean (standard deviation) or sample size and percentage displayed

From: Opioid legislation and narcotic filling in total hip arthroplasty: descriptive study of time and state-level trends in the United States

Timeframe

Oxycodone 5-mg equivalents (first prescription)

Oxycodone 5-mg equivalents (cumulative)

1 or more opioid prescriptions

2 or more opioid prescriptions

Initial volume > 90 oxycodone 5-mg equivalents

2010

56.2 (38.9)

151.9 (105.3)

12,917 (59.5%)

8171 (37.6%)

1387 (6.4%)

2011

55.8 (38.7)

141.8 (105.7)

39,590 (64%)

26,208 (42.4%)

4319 (7%)

2012

56.8 (38.6)

140.8 (104.9)

42,277 (64%)

27,684 (41.9%)

4901 (7.4%)

2013

57.5 (38.3)

140.2 (104.5)

46,734 (66.2%)

30,102 (42.6%)

5666 (8%)

2014

58.7 (38.8)

139.8 (102.4)

50,784 (67.6%)

32,575 (43.4%)

6508 (8.7%)

2015

62.2 (39.9)

140.4 (101)

50,271 (67.8%)

31,286 (42.2%)

7622 (10.3%)

2016

61.5 (39.6)

136.8 (99.7)

51,373 (69.8%)

31,429 (42.7%)

7311 (9.9%)

2017

57.7 (37.3)

126.5 (96.1)

49,009 (70.2%)

29,448 (42.2%)

5619 (8.1%)

2018

51.7 (33.9)

111.7 (91.3)

19,943 (69.9%)

11,484 (40.3%)

1590 (5.6%)